Mereo BioPharma Group Plc (MREO)
0.3066
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
0.30
-0.01
(-2.15%)
After-Hours: 19:59
Mereo BioPharma Group Net Income (Quarterly) : -5.860M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -5.860M |
| June 30, 2026 | -7.018M |
| March 31, 2026 | -6.708M |
| December 31, 2025 | -7.340M |
| September 30, 2025 | -6.980M |
| June 30, 2025 | -14.80M |
| Date | Value |
|---|---|
| March 31, 2025 | -12.94M |
| December 31, 2024 | -6.981M |
| September 30, 2024 | -15.15M |
| June 30, 2024 | -12.27M |
| March 31, 2024 | -8.946M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -4.134M |
| BioNTech SE | 212.27M |
| Silence Therapeutics Plc | -- |
| Autolus Therapeutics Plc | -55.06M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.7996M |
| Total Expenses (Quarterly) | 6.660M |
| EPS Diluted (Quarterly) | -0.0364 |
| Enterprise Value | 23.19M |
| Gross Profit Margin (Quarterly) | 49.12% |
| Profit Margin (Quarterly) | -732.9% |
| Earnings Yield | -54.79% |
| Normalized Earnings Yield | -55.25 |